Dr Reddy's launches oral suspension drug in the US market
The newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for oral suspension. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma arm gets relief from US court in patent infringement case
The lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 26, 2018 Category: Pharmaceuticals Source Type: news

Strides gets USFDA nod to market laxative drug in US
The product will be manufactured at Strides' facility in Bengaluru and will be marketed by Strides Pharma in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 24, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches anti-coagulant drug in US market
Dr Reddy's Aspirin and extended-release Dipyridamole capsules is available in 25 mg/200 mg strength with 60 count bottle size. Aggrenox is a trademark of Boehringer lngelheim. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 24, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for 2 drugs
The group has more than 241 approvals, and so far filed over 340 abbreviated new drug applications (ANDAs) since it started filings in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 24, 2018 Category: Pharmaceuticals Source Type: news

Lupin partners with AbbVie to develop, commercialise novel oncology drug
Additionally, Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the programme in India, the company added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 24, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for anaesthesia drug
Quoting IQVIA data, Aurobindo Pharma said the approved product has an estimated market size of USD 11 million for the 12 months ending September 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 24, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma to launch potassium chloride pills in US
The tablet, a generic version of Upsher-Smith's Klor-Con extended release tablets, would be launched next month, said a press release here. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 21, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma arm gets USFDA nod for epilepsy drug
The subsidiary concerned had in-licensed Elepsia XR from Sun Pharma Advanced Research Company (SPARC) in July 2016. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 21, 2018 Category: Pharmaceuticals Source Type: news

Ranbaxy to ruins: How the Singh brothers turned from business whizkids to fraud accused
This is the story of the sorry fall of an empire that had risen from the ground up in the span of a few decades. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2018 Category: Pharmaceuticals Source Type: news

E-pharmacies group appeals ruling to shut down business
The court had asked e-pharmacies to stop business, raising alarm among private equity funds that have invested nearly Rs 300 crore in them. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2018 Category: Pharmaceuticals Source Type: news

3.36% of about 82,600 drugs samples found to be substandard
Of the total, 236 samples or 0.28 per cent were declared spurious or adulterated, Minister of State Chemicals and Fertilisers Mansukh L Mandaviya told the Lok Sabha. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2018 Category: Pharmaceuticals Source Type: news

HC dismisses Monsanto plea against CCI probe of directors
A bench of Chief Justice Rajendra Menon and Justice V K Rao said the officers or directors of a company can be proceeded against, along with the entity. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2018 Category: Pharmaceuticals Source Type: news

Madras HC bars e-sale of drugs from Thursday
The order says other countries like the US, which has new laws in place, also finds the enforcement of online pharmacies, a challenge. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2018 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets USFDA nod for ear drops
The company's current portfolio consists of 146 products authorised for distribution at the US marketplace and 54 abbreviated new drug applications (ANDAs) pending approval with the USFDA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2018 Category: Pharmaceuticals Source Type: news

Free pharma samples come under GST lens
The executives have to frequent the city to record statements or make submissions before authorities. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 17, 2018 Category: Pharmaceuticals Source Type: news

USFDA completes Biocon's Telangana plant inspection
The inspection was concluded without any observations and no Form 483 was issued, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 17, 2018 Category: Pharmaceuticals Source Type: news

Restrictive Delhi HC order pushes India's online pharmacies on the backfoot
Investors have continued to pour in significant amounts of capital in the burgeoning space, but the latest court decision is likely to affect future investments. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 14, 2018 Category: Pharmaceuticals Source Type: news

EU court upholds EUR 13.96 mn fine on Unichem Lab in Perindopril litigation
In 2014, six global drug makers were fined EUR 427.7 million for striking deals to prevent entry of cheaper version of blood pressure drug Perindopril in the EU. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 13, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches heartburn drug in US market
Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around $492 mn for the most recent 12 months ending in October 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Cadila Healthcare arm gets USFDA nod for ulcer treatment injection
The company has more than 237 approvals, and has so far filed over 340 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma arm enters pact to form JV in China with Luoxin
"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma promoters take a hit on personal investments
Some of their biggest personal investments have been in power and real estate, and both sectors and their holdings have taken a beating, according to publicly available data. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution
The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solution USP, 0.1 per cent, Alembic Pharmaceuticals said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 10, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets EIR from USFDA for Pithampur facility unit
Lupin's Pithampur facility manufactures dermatological products, dry product inhalers, and metered dose inhalers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 10, 2018 Category: Pharmaceuticals Source Type: news

USFDA recommends regulatory action after Jubilant Life's Roorkee plant inspection
According to the FDA, Official Action Indicated means regulatory and/or administrative actions will be recommended against a facility after an inspection. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2018 Category: Pharmaceuticals Source Type: news

Malvinder and Shivinder Singh trade assault charges
While Shivinder in a statement has denied these claims and instead alleged that it was Malvinder who assaulted him, his elder brother has alleged that Shivinder disrupted the meeting of the company, which owes them dues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 8, 2018 Category: Pharmaceuticals Source Type: news

USFDA makes 22 observations post inspection of Lupin's Mandideep facilities
Lupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalosporin API block ” and the company is confident of addressing them satisfactorily. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Novartis India MD Milan Paleja to step down
Milan Paleja has informed the company's board of his decision to resign as the vice chairman and managing director effective May 31, 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Investors irked by lack of disclosures at Sun Pharma
The lack of disclosures around non-related party transactions to the tune of Rs 2,200 crore has become a sore spot for investors, who are questioning the nature — and beneficiaries — of these loans. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma open to evaluating past decisions: Dilip Shanghvi
A WhatsApp forward leaked details of a report containing allegations of corporate governance improprieties (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 4, 2018 Category: Pharmaceuticals Source Type: news

Report on faulty hip replacement implants ready: Centre to SC
The apex court on October 5 had asked the Centre to file its response to the PIL alleging that "faulty" and "deadly" hip implants have been fitted into the bodies of 4,525 Indian patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2018 Category: Pharmaceuticals Source Type: news

Sun Pharma says open to evaluating certain business transactions if investors not comfortable with them
As of now the company has not received any query from Sebi with regard to whistleblower complaint, Sun Pharma Founder and MD Dilip Shanghvi said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2018 Category: Pharmaceuticals Source Type: news

Whistle-blower complains to SEBI against Sun Pharma, alleges insider trading: Report
150-page document sent to market regulator in September, drugmaker says it has not yet been contacted by SEBI. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 1, 2018 Category: Pharmaceuticals Source Type: news

Kiran Mazumdar Shaw bats for easing regulations on biotechnology sector
"The erstwhile UPA regime and the present Modi government have taken some good steps, but have not done enough to improve the economy," Shaw said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2018 Category: Pharmaceuticals Source Type: news

Patients with faulty Johnson & Johnson hip implants to be compensated up to Rs 1.23 crore
According to a statement issued by the ministry, patients who had received faulty hip implants prior to August, 2010 will be eligible for the compensation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2018 Category: Pharmaceuticals Source Type: news

Jubilant Life arm inks pact to acquire Inipharm Inc for around USD 28.5 mn
Drug firm Jubilant Life Sciences' subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered into an agreement to acquire 10 per cent stake in Inipharm Inc USA (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 29, 2018 Category: Pharmaceuticals Source Type: news

Lupin CFO quits, to pursue opportunities outside pharma
Swaminathan as the CFO of Lupin, was part of some of company's biggest mergers and acquisition in US and Japan (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 27, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for insomnia treatment drug
The company has got approval from the US Food and Drug Administration (USFDA) to market the drug. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 27, 2018 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for Alembic Pharma
The approved product is therapeutically equivalent to AstraZeneca Pharmaceuticals' Xylocaine ointment, 5 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for antidepressant drug
The capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD), Lupin said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2018 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets tentative USFDA nod for skin treatment drug
The approved product is a generic version of Mylan Pharmaceuticals Inc's drug (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2018 Category: Pharmaceuticals Source Type: news

Lupin launches first chatbot for patients to know about their ailments
As a start to digitize the patient journey in the overall healthcare space, Lupin is starting with ANYA to address queries related to diabetes. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 23, 2018 Category: Pharmaceuticals Source Type: news

77 percent Indian households use Ayurvedic products: PwC report
The size of the global Ayurvedic market is expected to almost treble from $3.4 billion in 2015 to $9.7 billion by 2022. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 23, 2018 Category: Pharmaceuticals Source Type: news

High Court quashes Abbott ’s plea to stall CCI probe into alleged cartelisation
Justice Vibhu Bakhru dismissed the petition on the grounds that there was no merit in the plea. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 20, 2018 Category: Pharmaceuticals Source Type: news

Indian ayurvedic industry to grow to $ 4.4 billion by the end of this year
To add to the bullish outlook, the Indian ayurveda industry is projected to record a compounded annual growth rate of a robust 16 % until 2025. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 19, 2018 Category: Pharmaceuticals Source Type: news

E-pharmacies divided over their legal status
Madras High Court will hear a petition from Tamil Nadu Chemists and Druggists Association that has challenged the existence of e-pharmacies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 19, 2018 Category: Pharmaceuticals Source Type: news

ICMR to conduct trials of indigenously developed Zika vaccine
ICMR will undertake phase-II trial of the vaccine to establish the efficacy and safety of the vaccine along with its adverse effects. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 18, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma to launch oncology, respiratory products in US by 2021
The company is also focussing on securing intellectual property (IP) and ramping up and filing of specialty products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 18, 2018 Category: Pharmaceuticals Source Type: news

Glenmark gets USFDA nod for multiple sclerosis medication
The approved product is generic version of Sanofi-Aventis US' Aubagio. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2018 Category: Pharmaceuticals Source Type: news